Babaei Amirhossein, Iravani Kamyar, Malekpour Behzad, Golkhar Behnaz, Soltaniesmaeili Amir, Hosseinialhashemi Milad
Otolaryngology Research Center, Department of Otolaryngology Shiraz University of Medical Sciences Shiraz Iran.
Student Research Committee Shiraz University of Medical Sciences Shiraz Iran.
Laryngoscope Investig Otolaryngol. 2021 Nov 2;6(6):1248-1255. doi: 10.1002/lio2.690. eCollection 2021 Dec.
The present study aimed to assess the 4- and 8-week recovery rate of anosmia and determine the factors associated with recovery in COVID-19 patients.
This retrospective study was conducted from December 2020 to March 2021. RT-PCR-proven COVID-19 adult patients (over 18 years of age) with a positive history of anosmia were included in this study. Anosmia was assessed based on the COVID-19 Anosmia Reporting Tool. The recovery rate of anosmia after 4 and 8 weeks were evaluated, and the relationship between the patients' recovery and their clinical and demographic data was assessed.
A total of 235 patients were included. Their mean age (±SD) was 43.95 ± 15.27 years. Anosmia recovery was reported in 207(88.51%) and 219 (93.19%) participants till 4 and 8 weeks. The mean recovery time was 19.42 ± 8.81 days. The result of logistic regression showed that smoking ( = .031; OR = 10.813), ageusia ( = .002; OR = 5.340), headache ( = .006; OR = 0.243), and nasal discharge ( < .001; OR = 0.080) were significantly associated with 4 weeks anosmia recovery. The only risk factor which was associated with a lower rate of 8 weeks anosmia recovery was presence of nasal discharge (OR = 0.106, = .002).
The only risk factor which was associated with a lower rate of 8 weeks anosmia recovery was presence of nasal discharge. Our result demonstrated that although smoking was associated with higher recovery rate till 4 weeks, it could not be considered as a protective factor after 8 weeks. More studies are recommended to investigate the relationship between anosmia and the associated factors by consideration of both short- and long-term recovery rates and assess the possible mechanisms that could justify this association.
3b.
本研究旨在评估新型冠状病毒肺炎(COVID-19)患者嗅觉丧失的4周和8周恢复率,并确定与恢复相关的因素。
本回顾性研究于2020年12月至2021年3月进行。纳入经逆转录聚合酶链反应(RT-PCR)证实的有嗅觉丧失阳性病史的COVID-19成年患者(年龄超过18岁)。根据COVID-19嗅觉丧失报告工具评估嗅觉丧失情况。评估4周和8周后嗅觉丧失的恢复率,并评估患者恢复情况与其临床和人口统计学数据之间的关系。
共纳入235例患者。他们的平均年龄(±标准差)为43.95±15.27岁。到4周和8周时,分别有207例(88.51%)和219例(93.19%)参与者报告嗅觉恢复。平均恢复时间为19.42±8.81天。逻辑回归结果显示,吸烟(P = 0. 031;比值比[OR]=10.813)、味觉丧失(P = 0.002;OR = 5.340)、头痛(P = 0.006;OR = 0.243)和流涕(P < 0.001;OR = 0.080)与4周嗅觉恢复显著相关。与8周嗅觉恢复率较低相关的唯一危险因素是流涕(OR = 0.106,P = 0.002)。
与8周嗅觉恢复率较低相关的唯一危险因素是流涕。我们的结果表明,虽然吸烟与4周时较高的恢复率相关,但8周后不能将其视为保护因素。建议进行更多研究,通过考虑短期和长期恢复率来调查嗅觉丧失与相关因素之间的关系,并评估可能解释这种关联的潜在机制。
3b。